photo
Kevin C Abbott

Nephrology Service, Clinical Information System, Walter Reed Army Medical Center, Washington, DC 20307, USA.


1
Kevin C Abbott, Erin M Bohen, Christina M Yuan, Frederick E Yeo, Eric S Sawyers, Robert M Perkins, Krista L Lentine, David K Oliver, Joanie Galey, Mary E Sebastianelli, John P Scally, Allen J Taylor, Thomas R Boal “Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system.”, Am. J. Kidney Dis., vol. 47, no. 4, 2006
View At Pubmed
2
Kevin C Abbott, Jonathan Koff, Erin M Bohen, Robert J Oglesby, Lawrence Y C Agodoa, Krista L Lentine, Mark A Schnitzler “Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States.”, Transplantation, vol. 79, no. 3, 2005
View At Pubmed
3
Kevin C Abbott, Victor J Bernet, Lawrence Y Agodoa, Christina M Yuan “Differing manifestations of hepatitis C and tacrolimus on hospitalized diabetes mellitus occurring after kidney transplantation.”, Ann Epidemiol, vol. 15, no. 8, 2005
View At Pubmed
4
Kevin C Abbott, Paul L Kimmel, Vikas Dharnidharka, Robert J Oglesby, Lawrence Y Agodoa, Sophie Caillard “New-onset gout after kidney transplantation: incidence, risk factors and implications.”, Transplantation, vol. 80, no. 10, 2005
View At Pubmed
5
Kevin C Abbott, Fernando C Trespalacios, Lawrence Y Agodoa, Tejinder S Ahuja “HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study.”, BMC Nephrol, vol. 4, 2004
View At Pubmed
6
Kevin C Abbott, Fernando C Trespalacios, Lawrence Y Agodoa “Arteriovenous fistula use and heart disease in long-term elderly hemodialysis patients: analysis of United States Renal Data System Dialysis Morbidity and Mortality Wave II.”, J. Nephrol., vol. 16, no. 6, 2004
View At Pubmed
7
Kevin C Abbott, David F Cruess, Lawrence Y C Agodoa, Eric S Sawyers, Daniel P Tveit “Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States.”, Am. J. Kidney Dis., vol. 43, no. 1, 2004
View At Pubmed
8
Kevin C Abbott, Christopher W Glanton, Fernando C Trespalacios, David K Oliver, Maria I Ortiz, Lawrence Y Agodoa, David F Cruess, Paul L Kimmel “Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study.”, Kidney Int., vol. 65, no. 2, 2004
View At Pubmed
9
Kevin C Abbott, S John Swanson, Lawrence Y C Agodoa, Paul L Kimmel “Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression.”, J. Am. Soc. Nephrol., vol. 15, no. 6, 2004
View At Pubmed
10
Kevin C Abbott, S John Swanson, Erich R Richter, Erin M Bohen, Lawrence Y Agodoa, Thomas G Peters, Galen Barbour, Robert Lipnick, David F Cruess “Late urinary tract infection after renal transplantation in the United States.”, Am. J. Kidney Dis., vol. 44, no. 2, 2004
View At Pubmed
11
Kevin C Abbott, Krista L Lentine, Jay R Bucci, Lawrence Y Agodoa, Thomas G Peters, Mark A Schnitzler “The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients.”, Am. J. Transplant., vol. 4, no. 12, 2004
View At Pubmed
12
Kevin C Abbott, Krista L Lentine, Jay R Bucci, Lawrence Y Agodoa, Jonathan M Koff, Kent C Holtzmuller, Mark A Schnitzler “Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus.”, J. Am. Soc. Nephrol., vol. 15, no. 12, 2004
View At Pubmed
13
Kevin C Abbott, Fernando C Trespalacios, Lawrence Y Agodoa, Allen J Taylor, George L Bakris “beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality.”, Arch. Intern. Med., vol. 164, no. 22, 2004
View At Pubmed
14
Kevin C Abbott, Lawrence Y Agodoa “Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival.”, BMC Nephrol, vol. 3, 2004
View At Pubmed
15
Kevin C Abbott, Franco M Musio, Ellen M Chung, Nick N Lomis, John D Lane, Christina M Yuan “Transjugular renal biopsy in high-risk patients: an American case series.”, BMC Nephrol, vol. 3, 2004
View At Pubmed
16
Kevin C Abbott, Rebecca A Viola, Lawrence Y Agodoa “Hospitalized poisonings after renal transplantation in the United States.”, BMC Nephrol, vol. 3, 2004
View At Pubmed
17
Kevin C Abbott, Fernando C Trespalacios, Allen J Taylor, Lawrence Y Agodoa “Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality.”, BMC Nephrol, vol. 4, 2004
View At Pubmed
18
Kevin C Abbott, Jay R Bucci, Lawrence Y Agodoa “Total hip arthroplasty in chronic dialysis patients in the United States.”, J. Nephrol., vol. 16, no. 1, 2003
View At Pubmed
19
Kevin C Abbott, Christopher W Glanton, Lawrence Y Agodoa “Body mass index and enrollment on the renal transplant waiting list in the United States.”, J. Nephrol., vol. 16, no. 1, 2003
View At Pubmed
20
Kevin C Abbott, Joel C Reynolds, Fernando C Trespalacios, David Cruess, Lawrence Y Agodoa, “Survival by time of day of hemodialysis: analysis of United States Renal Data System Dialysis Morbidity and Mortality Waves III/IV.”, Am. J. Kidney Dis., vol. 41, no. 4, 2003
View At Pubmed
21
Kevin C Abbott, Noah Schenkman, S John Swanson, Lawrence Y Agodoa “Hospitalized nephrolithiasis after renal transplantation in the United States.”, Am. J. Transplant., vol. 3, no. 4, 2003
View At Pubmed
22
Kevin C Abbott, Joel C Reynolds, Allen J Taylor, Lawrence Y Agodoa “Hospitalized atrial fibrillation after renal transplantation in the United States.”, Am. J. Transplant., vol. 3, no. 4, 2003
View At Pubmed
23
K C Abbott, P Hshieh, D Cruess, L Y C Agodoa, P G Welch, A J Taylor, C M Yuan “Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes.”, Clin. Nephrol., vol. 59, no. 2, 2003
View At Pubmed
24
Kevin C Abbott, Christina M Yuan, Allen J Taylor, David F Cruess, Lawrence Y C Agodoa “Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression.”, J. Am. Soc. Nephrol., vol. 14, no. 9, 2003
View At Pubmed
25
Kevin C Abbott, Jay R Bucci, Cal S Matsumoto, S John Swanson, Lawrence Y C Agodoa, Kent C Holtzmuller, David F Cruess, Thomas G Peters “Hepatitis C and renal transplantation in the era of modern immunosuppression.”, J. Am. Soc. Nephrol., vol. 14, no. 11, 2003
View At Pubmed
26
Kevin C Abbott, Jay R Bucci, David Cruess, Allen J Taylor, Lawrence Y C Agodoa “Graft loss and acute coronary syndromes after renal transplantation in the United States.”, J. Am. Soc. Nephrol., vol. 13, no. 10, 2002
View At Pubmed
27
K C Abbott, I Hypolite, R K Poropatich, P Hshieh, D Cruess, C A Hawkes, L Y Agodoa, R A Keller “Hospitalizations for fungal infections after renal transplantation in the United States.”, Transpl Infect Dis, vol. 3, no. 4, 2002
View At Pubmed
28
K C Abbott, L Y Agodoa “Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival.”, Clin. Nephrol., vol. 57, no. 3, 2002
View At Pubmed
29
Kevin C Abbott, Lawrence Y Agodoa “Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States.”, Nephron, vol. 91, no. 2, 2002
View At Pubmed
30
Kevin C Abbott, Fernando C Trespalacios, Paul G Welch, Lawrence Y C Agodoa “Scleroderma at end stage renal disease in the United States: patient characteristics and survival.”, J. Nephrol., vol. 15, no. 3, 2002
View At Pubmed
31
Daniel P Tveit, Paul Hshieh, David Cruess, Lawrence Y C Agodoa, Paul G Welch, Kevin C Abbott “Risk factors for pulmonary embolism in chronic dialysis patients.”, J. Nephrol., vol. 15, no. 3, 2002
View At Pubmed
32
Kevin C Abbott, Malcolm G Napier, Lawrence Y C Agodoa “Hospitalizations for bacterial septicemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list.”, J. Nephrol., vol. 15, no. 3, 2002
View At Pubmed
33
K C Abbott, I O Hypolite, L Y Agodoa “Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival.”, Clin. Nephrol., vol. 58, no. 1, 2002
View At Pubmed
34
K C Abbott, E S Sawyers, J D Oliver, C W Ko, A D Kirk, P G Welch, T G Peters, L Y Agodoa “Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States.”, Am. J. Kidney Dis., vol. 37, no. 2, 2001
View At Pubmed
35
K C Abbott, J D Oliver , I Hypolite, L L Lepler, A D Kirk, C W Ko, C A Hawkes, C A Jones, L Y Agodoa “Hospitalizations for bacterial septicemia after renal transplantation in the united states.”, Am. J. Nephrol., vol. 21, no. 2, 2001
View At Pubmed
36
K C Abbott, R J Oglesby, I O Hypolite, A D Kirk, C W Ko, P G Welch, L Y Agodoa, W E Duncan “Hospitalizations for fractures after renal transplantation in the United States.”, Ann Epidemiol, vol. 11, no. 7, 2001
View At Pubmed
37
K C Abbott, L Y Agodoa “Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.”, Clin. Nephrol., vol. 56, no. 3, 2001
View At Pubmed
38
K C Abbott, M Duran, I Hypolite, C W Ko, C A Jones, L Y Agodoa “Hospitalizations for bacterial endocarditis after renal transplantation in the United States.”, J. Nephrol., vol. 14, no. 5, 2001
View At Pubmed
39
K C Abbott, I O Hypolite, P Hshieh, D Cruess, L Y Agodoa, P G Welch, A J Taylor, C M Yuan “The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes.”, J. Nephrol., vol. 14, no. 5, 2001
View At Pubmed
40
K C Abbott, I Hypolite, P G Welch, L Y Agodoa “Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.”, J. Nephrol., vol. 14, no. 5, 2001
View At Pubmed
Keywords
 Adrenergic beta-Antagonists  adverse effects  African Continental Ancestry Group  AIDS-Associated Nephropathy  analysis  Anemia, Sickle Cell  Angiotensin-Converting Enzyme Inhibitors  Anti-Retroviral Agents  Arteriovenous Shunt, Surgical  Arthroplasty, Replacement, Hip  Aspirin  Atrial Fibrillation  Bacteremia  Biopsy, Needle  blood  Body Mass Index  chemically induced  Circadian Rhythm  complications  Coronary Disease  Cyclosporine  Diabetes Complications  Diabetes Mellitus  Diabetes Mellitus, Type 2  drug therapy  Endocarditis, Bacterial  epidemiology  ethnology  etiology  Fractures, Bone  Glomerulosclerosis, Focal Segmental  Gout  Graft Rejection  Graft Survival  Heart Diseases  Heart Failure  Heart Valve Diseases  Hematocrit  Hepatitis C  Hepatitis C Antibodies  HIV Infections  Hospitalization  Immunoglobulin Light Chains  immunology  Immunosuppression  Immunosuppressive Agents  Kidney  Kidney Calculi  Kidney Diseases  Kidney Failure, Chronic  Kidney Transplantation  Life Tables  metabolism  methods  mortality  Multiple Myeloma  Mycoses  Myocardial Infarction  Obesity  pathology  Patient Selection  Peritoneal Dialysis  pharmacology  poisoning  Polycystic Kidney Diseases  Postoperative Complications  prevention & control  Pulmonary Embolism  Registries  Renal Dialysis  Renal Insufficiency  Scleroderma, Localized  statistics & numerical data  surgery  Tacrolimus  therapeutic use  therapy  Thromboembolism  Tissue Donors  transmission  Urinary Tract Infections  utilization  virology  Waiting Lists

No Biography Available.